2023
DOI: 10.1101/2023.10.30.23297594
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Nationwide population-based infection- and vaccine-induced SARS-CoV-2 seroprevalence in Germany at the end of 2021

Elisabetta Mercuri,
Lorenz Schmid,
Christina Poethko-Müller
et al.

Abstract: SummaryBackgroundThe first wave of the Corona Monitoring Nationwide (RKI-SOEP) Study drawn from the German Socio-Economic Panel proved a low pre-vaccine SARS-CoV-2 seroprevalence in the German adult population of 2.1%.MethodsIn this second wave of the study (RKI-SOEP-2, November 2021-March 2022), we used combined serological and self-reported data on infection and vaccination to estimate the prevalence of SARS-CoV-2-specific anti-spike and/or anti-nucleocapsid IgG antibodies (combined seroprevalence), past inf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…To determine seropositivity for anti-N antibodies in dried blood samples, the ratio cut point for serum samples provided by the manufacturer was adapted from 1.1 to 0.95 ( 30 ). A positive SARS-CoV-2 infection status was defined as either having self-reported a previous PCR-confirmed infection or seropositivity for anti-N antibodies or, in the absence of self-reported vaccination, seropositivity for anti-S antibodies ( 29 ). Infections might have occurred between the onset of the pandemic in Germany and the date of individual study participation.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…To determine seropositivity for anti-N antibodies in dried blood samples, the ratio cut point for serum samples provided by the manufacturer was adapted from 1.1 to 0.95 ( 30 ). A positive SARS-CoV-2 infection status was defined as either having self-reported a previous PCR-confirmed infection or seropositivity for anti-N antibodies or, in the absence of self-reported vaccination, seropositivity for anti-S antibodies ( 29 ). Infections might have occurred between the onset of the pandemic in Germany and the date of individual study participation.…”
Section: Methodsmentioning
confidence: 99%
“…Outcome: SARS-CoV-2 infections SARS-CoV-2 infection status was assessed by using individual self-reports and serological assays for SARS-CoV-2 antibodies (29). The Euroimmun enzyme-linked immunosorbent assays (ELISA) anti-SARS-CoV-2-QuantiVac and anti-SARS-CoV-2-NCP were used for the detection of anti-S (S1 domain of the spike protein) and anti-N (nucleocapsid protein, NCP) antibodies.…”
Section: Study Design and Populationmentioning
confidence: 99%